IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM?
the analysis of foreign pricing and drug supply public funding systems (or a so-called drug reimbursement) shows a substantial variety and presence of national peculiarities; however the majority of the developed foreign countries apply reference pricing. As part of the introduction of reference pri...
Main Author: | V. V. Omelyanovskiy |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2015-05-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/89 |
Similar Items
-
The impact of external reference pricing on pharmaceutical costs and market dynamics
by: Dominic Voehler, et al.
Published: (2023-12-01) -
How does external reference pricing work in developing countries: evidence from Iran
by: Fatemeh Babaie, et al.
Published: (2023-06-01) -
Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model
by: Iris an der Heiden, et al.
Published: (2024-04-01) -
Dynamics of price competition in Italian pharmaceutical off-patent market
by: Serena Perna, et al.
Published: (2022-11-01) -
ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS
by: M. V. Sura, et al.
Published: (2015-05-01)